EC Number   |
Application |
Reference |
|---|
   3.4.21.117 | diagnostics |
human kallikrein 7 can potentially be used as a biomarker for the characterization of different stages of cervical disease |
708770 |
| 3.4.21.117 | diagnostics |
potential biomarkers for several carcinomas and other diseases, prognostic value of KLK7 mRNA expression in colorectal cancer tissue giving, upregulation of KLK7 expression gives a poor prognosis, overview |
710599 |
| 3.4.21.117 | diagnostics |
the enzyme is a biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression, overview |
677579 |
| 3.4.21.117 | diagnostics |
the enzyme is a potential biomarker of ovarian cancer |
682553 |
| 3.4.21.117 | diagnostics |
the enzyme is a prognostic biomarker for ovarian cancer, but cannot be used independent from other markers, overview |
683366 |
| 3.4.21.117 | diagnostics |
the enzyme might be a prognostic biomarker for breast cancer |
664622 |
| 3.4.21.117 | medicine |
because the enzyme appears only in abundance in tumor tissue and contains a secretion signal sequence, suggesting that the enzyme is secreted, it may prove to be a useful diagnostic/prognostic tool for the detection of metastatic or recurrent disease or as a novel molecular target for cervical cancer therapy |
665069 |
| 3.4.21.117 | medicine |
breast cancer patients with KLK7 positive tumors have relatively shorter disease-free survival and overall survival than patients with KLK7 negative tumors. KLK7 gene expression may be used as a marker of unfavorable prognosis for breast cancer patients |
666961 |
| 3.4.21.117 | medicine |
ectopic expression of KLK7 in pancreatic cancer cells leads to a reduction in cell adhesion to vitronectin that may result from the cleavage of uPAR from the cell surface. KLK 7 expression, plays an important role in the dissemination of tumor cells through the production of soluble uPAR in pancreatic cancer |
700554 |
| 3.4.21.117 | medicine |
expression of full-length KLK7 mRNA may represent a new prognostic marker in breast cancer disease |
664622 |
